CYP27B1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP27B1 monoclonal antibodies for research focused on understanding this critical enzyme. CYP27B1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP27B1, also known as 25-hydroxyvitamin D3 1-alpha-hydroxylase, is essential for the conversion of 25-hydroxyvitamin D into its active form, calcitriol. The enzyme plays a pivotal role in calcium homeostasis and bone metabolism, influencing various physiological processes. Dysregulation of CYP27B1 has been implicated in several diseases, including osteoporosis and certain cancers, highlighting its significance in both health and disease. Research utilizing CYP27B1 monoclonal antibodies enables detailed investigation of vitamin D metabolism pathways. Understanding CYP27B1 function and regulation provides valuable insights into potential therapeutic strategies for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies for CYP27B1 support researchers worldwide in advancing our understanding of vitamin D metabolism and its impact on human health.